Navigation Links
New Compound Offers Hope In Liver Cancer Treatment

The identification of a novel compound, CDDO-Im, shown to possess strong anti-tumor properties in studies conducted on animal models could soon revolutionize the treatment of liver cancer patients. // The compound has been found to increase the intrinsic resistance to carcinogens (cancer causing substances) by enhancing the function of enzymes that remove toxins from the body. Further results about the compound have been published in the journal Cancer Research.

The compound has been found to be active (100 times effective than other anti-tumor compounds) at very small doses. It is hoped that the compound could play an important role in the prevention of cancers associated with inflammation such as lung cancer, liver cancer, prostate cancer and gastric cancer. It can also help in the treatment of asthma, emphysema or other neurodegenerative disorders, linked to inflammation.

The synthetic compound, a derivative of oleanolic acid, belongs to a class of compounds commonly referred to as triterpenoids. Previous studies have established the anti-tumor properties of oleanolic derivatives in animals and humans.

In order to assess the effectiveness of cancer prevention, the researchers treated rats with aflatoxin, a carcinogen, known to cause liver cancer. The rates were treated with 0.1, 0.3, 1.0, 3.0 or 10 micromole doses of CDDO-Im. As much as 85% reduction in the incidence of pre-cancerous lesions could be observed when rats were treated with 0.1 mmol of the compound. This anti-cancer property could be due to associated activation of Nrf2 protein. This protein is believed to play a major role in the protection of body against environmental toxins.

The results of this study have several important clinical applications. First, it could lead to the development of new cancer prevention strategies. Second, it can attenuate the clinical features and provide relief to those suffering from inflammatory diseases. Third, it can pro tect humans from several diseases that can be attributed to a specific environmental agent.


'"/>




Related medicine news :

1. Compound of Broccoli combats breast cancer
2. New Compound Could Strengthen The Effect Of Chemotherapy
3. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
4. Compound from cottonseed for neck and head cancers
5. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
6. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
7. Compound In Grapes And Red Wine To Counter Alzheimers Disease
8. Sugars Could Contain Key Cancer Inhibiting Compounds
9. Compound From Cyanobacterium Can Fight Alzheimer’
10. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
11. Compounds in Licorice Can Fight Tooth Decay
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... The Honolulu cosmetic and ... website, which launched October 17, 2016, features comprehensive information regarding a wide range ... Visitors and patients can discover the latest clinical dermatology treatments for medical skin ...
(Date:12/7/2016)... Dallas, TX (PRWEB) , ... December 07, 2016 ... ... a 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. ... Awards recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken ...
(Date:12/7/2016)... Scottsdale, AZ (PRWEB) , ... ... ... pioneer, ElectroMedical Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus ... , WellnessPro Plus substantially enhances the WellnessPro platform by expanding the treatment ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Walking With God: ... stories that will inspire the reader to be aware of God's direction in their ... published author, Sanford Smith, retired teacher and active church leader. , Sanford ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, ... International Probiotic Association’s Washington DC workshop on November 2nd. The conference was an ... regarding probiotic dietary supplement regulations. , Dr. Leyer spoke about two main ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Eurofins Genomics today ... the College of American Pathologists (CAP) and certification ... its new laboratory in Louisville, KY ... North American headquarters. "Our new CLIA-licensed ... which is still considered the ,Gold Standard, method ...
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... 2016  Regulus Therapeutics Inc. (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... R&D day, held in New York ... anti-miR targeting microRNA-27 (miR-27) for the treatment of ... anti-miR targeting microRNA-17 (miR-17) for the treatment of ...
Breaking Medicine Technology: